Promega, JA2351, 4-1BB Bioassay

A Simpler, More Consistent 4-1BB Bioassay
Prequalified according to ICH guidelines
Mechanism-of-action (MOA)-based assay
No primary cell culture required
Supplied in convenient thaw-and-use format; also available in cell propagation model (CPM) format
Specifications：
4-1BB Effector Cells J235A 1 × .5ml
Fetal Bovine Serum J121A 1 × 4ml
RPMI 1640 Medium G708A 1 × 36ml
Bio-Glo™ Luciferase Assay Buffer G719A 1 × 10ml
Bio-Glo™ Luciferase Assay Substrate G720A 1 × 1 vial
4-1BB Effector Cells J235A 5 × .5ml
Fetal Bovine Serum J121A 5 × 4ml
RPMI 1640 Medium G708A 5 × 36ml
Bio-Glo™ Luciferase Assay Buffer G719A 5 × 10ml
Bio-Glo™ Luciferase Assay Substrate G720A 5 × 1 vial
4-1BB Effector Cells (CPM) J233A 2 × 1ml
Control Ab, Anti-4-1BB K116A 1 × 50μg
4-1BB (CD137/TNFRSF9), a member of the tumor necrosis factor receptor superfamily, is an inducible co-stimulatory receptor expressed on T cells, natural killer (NK) cells and innate immune cell populations. When present on the cell surface, 4-1BB interacts with 4-1BB ligand (4-1BBL) and induces subsequent cell proliferation and production of interferon gamma (IFNγ) and interleukin-2 (IL-2), particularly in T and NK cells.
Current methods used to measure the activity of biologic drugs targeting 4-1BB rely on assays that are laborious and highly variable due to their reliance on donor primary cells, complex assay protocols and unqualified assay reagents and, as a result, are difficult to establish in a quality-controlled, drug-development setting.
The 4-1BB Bioassay is a biologically relevant, MOA-based assay that can be used to measure the potency and stability of ligands or agonist antibodies that can bind and activate 4-1BB.
Control Ab, Anti-4-1BB, is a mouse anti-human 4-1BB agonist antibody. It can be used as a positive control in the 4-1BB Bioassay in the presence of FcγRIIb CHO-K1 Cells (Cat.# JA2251, JA2255).